Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Deciphera Pharmaceuticals LLC"
Count: 14
Selected: 0
NCT IDTitle
NCT05059262Study of Vimseltinib for Tenosynovial Giant Cell Tumor
NCT04530981A Drug-Drug Interaction Study to Evaluate the Effect of Ripretinib on the Pharmacokinetics of a CYP2C8 Probe Substrate in Patients With Advanced GIST
NCT05080621Ripretinib in Combination With Binimetinib in Patients With Gastrointestinal Stromal Tumor (GIST)
NCT03069469Study of DCC-3014 in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor
NCT03601897A Phase 1b/2 Study of Rebastinib (DCC-2036) in Combination With Paclitaxel in Patients With Advanced or Metastatic Solid Tumors
NCT03717415A Study of Rebastinib (DCC-2036) in Combination With Carboplatin in Patients With Advanced or Metastatic Solid Tumors
NCT04892017A Safety, Tolerability and PK Study of DCC-3116 in Patients With RAS or RAF Mutant Advanced or Metastatic Solid Tumors.
NCT03353753Phase 3 Study of DCC-2618 vs Placebo in Advanced GIST Patients Who Have Been Treated With Prior Anticancer Therapies
NCT02571036A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies
NCT03673501A Study of DCC-2618 vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib
NCT04148092Expanded Access Program of Ripretinib (DCC-2618) for the Treatment of Patients With Advanced GIST
NCT02228811A Study of DCC-2701 in Participants With Advanced Solid Tumors
NCT00827138Study Safety and Preliminary Efficacy of DCC-2036 in Patients With Leukemias (Ph+ CML With T315I Mutation)
NCT02824575Rebastinib Plus Antitubulin Therapy With Paclitaxel or Eribulin in Metastatic Breast Cancer